Showing 1541-1550 of 1735 results for "".
- Low-Carbohydrate Diet May Be Associated With Lower Risk of Primary Open-Angle Glaucomahttps://modernod.com/news/low-carbohydrate-diet-may-be-associated-with-lower-risk-of-blinding-eye-disease-2/2478047/Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may lower the risk of the most common subtype of glaucoma. In a first-of-its-kind study, a researcher at New York Eye and Ear Infirmary of Mount Sinai (NYEE) helped discover that if at-risk groups a
- Low-Carbohydrate Diet May Be Associated With Lower Risk of Glaucomahttps://modernod.com/news/low-carbohydrate-diet-may-be-associated-with-lower-risk-of-blinding-eye-disease/2478030/Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may lower the risk of the most common subtype of glaucoma. In a first-of-its-kind study, a researcher at New York Eye and Ear Infirmary of Mount Sinai (NYEE) helped discover that if at-risk groups a
- Avellino Labs to Provide Corporate and Technology Updates at OIS and ASCRS in San Diegohttps://modernod.com/news/avellino-labs-to-provide-corporate-and-technology-updates-at-ois-and-ascrs-in-san-diego/2476522/Executives from Avellino Labs will be presenting at several events during the American Society of Cataract and Refractive Surgery annual meeting at the San Diego Convention Center and nearby venues, May 2-5, 2019. Known for its successful introduction of the world’s first DNA test to
- Diet Soda Linked to Increased Risk for Diabetic Retinopathyhttps://modernod.com/news/diet-soda-linked-to-increased-risk-for-diabetic-retinopathy/2476232/Drinking diet soda may increase the risk for proliferative diabetic retinopathy, according to a study published online in the September/October issue of Clinical and Experimental Ophthalmology, as
- Study: Dietary Supplements Don’t Prevent Chronic Diseasehttps://modernod.com/news/study-dietary-supplements-dont-prevent-chronic-disease/2476158/As the US nutritional and dietary supplements market remains robust — an estimated $41.1 billion in sales in 2016 — the Academy of Nutrition and Dietetics is cautioning against the routine and indiscriminate use of these dietary add-ons, according to a Medscape
- AAO: New Study Confirms Mediterranean Diet Prevents AMD Developmenthttps://modernod.com/news/aao-new-study-confirms-mediterranean-diet-prevents-a-leading-cause-of-blindness/2479827/Evidence is mounting that a poor diet plays an important role in the development of age-related macular degeneration (AMD). A large
- Valo Health Suspends Development of DR Drug Candidate After Phase 2 Study Resultshttps://modernod.com/news/valo-health-suspends-development-of-dr-drug-candidate-after-phase-2-study-results/2482594/Valo Health announced topline data from its phase 2 SPECTRA study of OPL-0401 in patients with diabetic retinopathy (DR). The study did not meet its primary or secondary endpoints based on the analysis in the prede&sh
- Bausch + Lomb's Surgical Planning Software, Eyetelligence, Now Fully Commercially Available in UShttps://modernod.com/news/bausch-lombs-surgical-planning-software-eyetelligence-now-fully-commercially-available-in-us/2484204/Bausch + Lomb announced that its surgical planning software, Eyetelligence, is now available to all US ophthalmologists. Eyetelligence is designed to streamline a clinic’s operations and bring connectivity into the OR. According to B+L, the software helps surgeons make quick
- EssilorLuxottica to Acquire Ophthalmic Lens Materials Division of PUcorehttps://modernod.com/news/essilorluxottica-to-acquire-ophthalmic-lens-materials-division-of-pucore/2482895/EssilorLuxottica has signed an agreement with the South Korean-based PUcore for the acquisition of all its assets and entities involved in the development, manufacturing and sale of monomers used in the production of high index ophthalmic lenses. The assets acquired by EssilorLuxottica inclu
- Nicox and Kowa Sign Agreement for Exclusive Rights to Glaucoma Treatment NCX 470 in US and Unlicensed Territorieshttps://modernod.com/news/nicox-and-kowa-sign-agreement-for-exclusive-rights-to-glaucoma-treatment-ncx-470-in-us-and-all-unlicensed-territories/2482889/Kowa has gained exclusive rights to develop and commercialize NCX 470, Nicox’s nitric oxide (NO)-donating bimatoprost eye drop for the lowering of IOP in patients with glaucoma or ocular hypertension in the US and all other territories of the world excludin